Genetics and Translational Genomics of Neuropsychiatric Disease

Research in the Pinto Lab is focused on identifying genes and biological pathways involved in neuropsychiatric disorders, including autism, epilepsy, schizophrenia, intellectual disability, and Rett syndrome-like phenotypes.

Our lab integrates various forms of genetic variation (deletions, duplications, single-point mutations, indels), with coding and non-coding gene expression, epigenetics and clinical data, using a combination of innovative high-throughput experimental and bioinformatics approaches, that altogether could implicate novel risk factors and provide insights into the mechanisms underlying these disorders.

The Pinto Lab is part of the Seaver Autism Center, the Mindich Child Health and Development Institute, the Friedman Brain Institute, and the Icahn Genomics Institute (previously known as Institute for Genomics and Multiscale Biology), and is located in the Hess Center for Science & Medicine. We are also affiliated with the Division of Psychiatric Genomics.

For information on how to participate in the Neurodevelopmental Disorders Research Program and our clinical genomics projects click here.